EBITDA for Intuitive Surgical (ISRG)
According to Intuitive Surgical's latest reported financial statements, the company's current EBITDA (TTM) is $3.76B USD. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Currently viewingEBITDASwitch metric
TTM (last 4 quarters)
$3.76B
YoY change
+28.9%
5Y CAGR
+22.3%
Peak year (2025)
$3.62B
Cumulative EBITDA
$24.87B
EBITDA history chart for Intuitive Surgical (ISRG) from 1998 to 2025
EBITDA history table for Intuitive Surgical (ISRG) from 1998 to 2025
| Fiscal year | Period ended | Reported | EBITDA | YoY |
|---|---|---|---|---|
| 2025 | $3.62B | +28.9% | ||
| 2024 | $2.81B | +29.6% | ||
| 2023 | $2.17B | +11.6% | ||
| 2022 | $1.94B | -8.8% | ||
| 2021 | $2.13B | +60.7% | ||
| 2020 | $1.33B | -15.9% | ||
| 2019 | $1.58B | +19.3% | ||
| 2018 | $1.32B | +14.2% | ||
| 2017 | $1.16B | +10.2% | ||
| 2016 | $1.05B | +26.7% | ||
| 2015 | $829.50M | +33.1% | ||
| 2014 | $623.40M | -32.2% | ||
| 2013 | $919.80M | -1.7% | ||
| 2012 | $935.90M | +26.3% | ||
| 2011 | $741.30M | +24.5% | ||
| 2010 | $595.60M | +44.6% | ||
| 2009 | $412.00M | +22.6% | ||
| 2008 | $335.92M | +52.9% | ||
| 2007 | $219.77M | +54.1% | ||
| 2006 | $142.62M | +88.9% | ||
| 2005 | $75.50M | +166.8% | ||
| 2004 | $28.30M | -2361.8% | ||
| 2003 | -$1.25M | -92.0% | ||
| 2002 | -$15.67M | -0.0% | ||
| 2001 | -$15.67M | -10.6% | ||
| 2000 | -$17.52M | +1.3% | ||
| 1999 | -$17.31M | -43.8% | ||
| 1998 | -$30.77M | — |
EBITDA values are taken from Intuitive Surgical's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
In 2025, Intuitive Surgical (ISRG) EBITDA totalled $3.62B – grew 28.9% year-over-year.
Over 2020–2025 (5 years), Intuitive Surgical EBITDA expanded at a +22.3% compound annual rate, sustaining 3 straight years of year-over-year growth.
The highest annual EBITDA of $3.62B was reported in 2025. The lowest in the available history was -$30.77M in 1998.
Within Healthcare, Intuitive Surgical (ISRG) ranks 9th among 8 peers we track. The peer median for EBITDA is $24.21B.
Intuitive Surgical EBITDA by Year
Intuitive Surgical EBITDA 2025: $3.62B
Intuitive Surgical EBITDA in 2025 was $3.62B, grew 28.9% from 2024. This figure represents the highest annual value in the available history.
Intuitive Surgical EBITDA 2024: $2.81B
Intuitive Surgical EBITDA in 2024 was $2.81B, grew 29.6% from 2023.
Intuitive Surgical EBITDA 2023: $2.17B
Intuitive Surgical EBITDA in 2023 was $2.17B, grew 11.6% from 2022.
Intuitive Surgical EBITDA 2022: $1.94B
Intuitive Surgical EBITDA in 2022 was $1.94B, declined 8.8% below 2021.
Intuitive Surgical EBITDA 2021: $2.13B
Intuitive Surgical EBITDA in 2021 was $2.13B.
See more financial history for Intuitive Surgical (ISRG).
Sector peers — EBITDA
Companies in the same sector as Intuitive Surgical, ranked by their latest EBITDA.
| Company | EBITDA | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $156.73B | Healthcare |
| Johnson & Johnson (JNJ) | $41.05B | Healthcare |
| Eli Lilly and Company (LLY) | $27.94B | Healthcare |
| Merck & Co., Inc. (MRK) | $25.36B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $23.06B | Healthcare |
| AstraZeneca PLC (AZN) | $19.83B | Healthcare |
| AbbVie Inc. (ABBV) | $17.63B | Healthcare |
| Amgen Inc. (AMGN) | $15.84B | Healthcare |
Frequently asked questions
What is Intuitive Surgical's EBITDA?
- Latest reported EBITDA for Intuitive Surgical (ISRG) is $3.76B (period ending March 31, 2026).
How has Intuitive Surgical EBITDA changed year-over-year?
- Intuitive Surgical (ISRG) EBITDA changed +28.9% year-over-year on the latest annual filing.
What is the long-term growth rate of Intuitive Surgical EBITDA?
- Intuitive Surgical (ISRG) EBITDA compound annual growth rate is +22.3% over the most recent 5 years available.
When did Intuitive Surgical EBITDA hit its highest annual value?
- Intuitive Surgical EBITDA reached its highest annual value of $3.62B in 2025.
What was Intuitive Surgical EBITDA in 2024?
- Intuitive Surgical (ISRG) EBITDA in 2024 was $2.81B.
What was Intuitive Surgical EBITDA in 2025?
- Intuitive Surgical (ISRG) EBITDA in 2025 was $3.62B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
ISRG Overview
Company profile, financial tools, and key metrics
ISRG Revenue Counter
Earns $335.56 every second. See per minute, hour, and day.
ISRG Earnings Counter
Earns $94.47 per second net profit. See per minute, hour, and day.
ISRG Economic Scale
Exceeds Bermuda's GDP. Compare with world economies.
ISRG What If Invested
What if you had invested $1,000? See historical returns from any date.
ISRG How It Makes Money
Discover visual breakdown of $10.58B in revenue — where it comes from and where it goes.
ISRG Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
ISRG Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
ISRG Daily Price Character
Explosive · 50.8% historical win rate (green days). Streaks & record days.
ISRG Buybacks
2.09% TTM buyback yield. Shareholder yield & SBC comparison.
ISRG Stock Split History
3 splits on record. Dates, ratios, and cumulative multiple.